Expertise in
19
conditions

Dr. Humberto I. Aguilar

Gastroenterology
Shreveport Endoscopy Center A M C
3217 Mabel St, 
Shreveport, LA 
Accepting New Patients
Expertise in
19
conditions
Shreveport Endoscopy Center A M C
3217 Mabel St, 
Shreveport, LA 

Overview

Humberto Aguilar is a Gastroenterologist practicing medicine in Shreveport, Louisiana.

Dr. Aguilar is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Hepatitis, Crohn's Disease, Ulcerative Colitis, Endoscopy, and Colonoscopy.

He is actively involved in clinical research, co-authoring 16 peer reviewed articles and participating in 22 clinical trials. Dr. Aguilar is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in LA

Hospital Affiliations

Christus Shreveport-Bossier Health System
Natchitoches Regional Medical Center
Jackson Parish Hospital
Willis Knighton Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Shreveport Endoscopy Center A M C
3217 Mabel St, Shreveport, LA 71103

Additional Areas of Focus

Dr. Aguilar has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

21 Clinical Trials

A Phase 4 Study Evaluating Real-World Use of CDPATH™, a Crohn's Disease Risk Prediction Tool
A Phase 4 Study Evaluating Real-World Use of CDPATH™, a Crohn's Disease Risk Prediction Tool
Enrollment Status: Active_not_recruiting
Publish Date: July 23, 2026
Intervention Type: Other
Study Phase: Phase 4
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Enrollment Status: Active_not_recruiting
Publish Date: May 14, 2026
A Phase 2, Randomized, Double-Blind, Comparator-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CRS3123 Compared With Oral Vancomycin in Adults With Clostridioides Difficile Infection
A Phase 2, Randomized, Double-Blind, Comparator-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CRS3123 Compared With Oral Vancomycin in Adults With Clostridioides Difficile Infection
Enrollment Status: Completed
Publish Date: March 27, 2026
Intervention Type: Drug
Study Drug: CRS3123
Study Phase: Phase 2
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2025
Intervention Type: Device, Diagnostic test
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
Enrollment Status: Completed
Publish Date: June 29, 2025
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
View 9 Less Clinical Trials

16 Total Publications

A multi-analyte cfDNA-based blood test for early detection of hepatocellular carcinoma.
A multi-analyte cfDNA-based blood test for early detection of hepatocellular carcinoma.
Journal: Journal of hepatology
Published: October 16, 2025
Similar Doctors
Expertise in
13
conditions
Dr. Qiang X. Cai
Gastroenterology
Expertise in
13
conditions
Dr. Qiang X. Cai
Gastroenterology
Referral may be required

BRFHH Shreveport LLC

1541 Kings Hwy, 
Shreveport, LA 
 (0.8 miles away)
318-626-0000
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients

Qiang Cai is a Gastroenterologist practicing medicine in Shreveport, Louisiana. Dr. Cai is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Gastroparesis, Achalasia, Gallbladder Disease, Gastrectomy, and Endoscopy. Dr. Cai is currently accepting new patients.

Expertise in
43
conditions
Dr. David F. Dies
Gastroenterology
Expertise in
43
conditions
Dr. David F. Dies
Gastroenterology
Referral may be required
Before you request

Shreveport Endoscopy Center A M C

3217 Mabel St, 
Shreveport, LA 
 (0.1 miles away)
318-631-9121
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Dies is a Gastroenterologist practicing medicine in Shreveport, Louisiana. Dr. Dies is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Hepatitis, Primary Biliary Cholangitis, Enlarged Liver, Gastrectomy, and Gastrostomy. Dr. Dies is currently accepting new patients.

Expertise in
51
conditions
Dr. Sathya Jaganmohan
Gastroenterology
Expertise in
51
conditions
Dr. Sathya Jaganmohan
Gastroenterology
Referral may be required

Willis Knight Bossier

2400 Hospital Dr, 
Bossier City, LA 
 (6.1 miles away)
318-212-7000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Sathya Jaganmohan is a Gastroenterologist practicing medicine in Bossier City, Louisiana. Dr. Jaganmohan is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Chronic Erosive Gastritis, Bile Duct Obstruction, Familial Pancreatic Cancer, Pancreatectomy, and Gastrectomy. Dr. Jaganmohan is currently accepting new patients.

Frequently Asked Questions about Dr. Humberto I. Aguilar

How do I make an appointment with Dr. Humberto I. Aguilar?

You can book an appointment with Dr. Humberto I. Aguilar by calling their office at 318-631-9121. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Humberto I. Aguilar a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Humberto I. Aguilar is classified as an Distinguished expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Humberto I. Aguilar specialize in?

While Dr. Humberto I. Aguilar is a Gastroenterology, they have specific expertise in Hepatitis, Crohn's Disease, and Ulcerative Colitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Humberto I. Aguilar participate in research or clinical trials?

Yes. Dr. Humberto I. Aguilar has published 16 articles and abstracts on conditions like Hepatitis. You can view a list of Dr. Humberto I. Aguilar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Humberto I. Aguilar accept my insurance?

Dr. Humberto I. Aguilar accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 318-631-9121 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Aguilar's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 50 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile